NCT04576286

Brief Summary

En bloc resection of bladder tumors (ERBT) may improve staging quality and perioperative morbidity and influence tumour recurrence

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jul 2020

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 24, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 16, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 6, 2020

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

4 years

First QC Date

September 16, 2020

Last Update Submit

January 25, 2025

Conditions

Keywords

urinary bladder tumorsen bloc resectionholmium laserbipolarTURBT

Outcome Measures

Primary Outcomes (1)

  • number of participant with Conversion to the TURBT

    conversion from the enbloc way of resection to the standard trans-urethral resection of bladder tumors

    intraoperative finding

Secondary Outcomes (10)

  • Operative time

    intraoperative finding

  • Presence of detrusor muscle in resected sample

    one day after surgery during pathological evaluation

  • Resected specimen's edge

    one day after surgery during pathological evaluation

  • intraoperative complication: bladder perforation

    intraoperative

  • Incidence of obturator reflex

    intraoperative

  • +5 more secondary outcomes

Study Arms (2)

Holmium en bloc resection

EXPERIMENTAL

Holmium en bloc resection procedure will be done under either general or spinal anesthesia, using a Holmium laser device (Cyber Ho, Quanta device, Milano, Italy). We will use a 30-40-watt power, 1-2 joules and 20-30 MHz frequency

Procedure: Holmium versus Bipolar en bloc transurethral resection

bipolar en bloc resection

ACTIVE COMPARATOR

bipolar en bloc tumor resection of urinary bladder tumors

Procedure: Holmium versus Bipolar en bloc transurethral resection

Interventions

After obtaining informed consent, patients will be randomized with a 1:1 ratio using sealed envelopes that will be prepared by the department's ethical committee into 2 groups, group 1 represent the Holmium en bloc resection procedure while group 2 represents bipolar en bloc resection. Patients will be blinded to the type of intervention as well as the data collector and the statistician. Intervention: all procedures will be done by an expert surgeon who performed over 50 cases of en bloc urinary bladder tumor resection with each energy source. In group A, Holmium en bloc resection procedure will be done under either general or spinal anesthesia, using a Holmium laser device (Cyber Ho, Quanta device, Milano, Italy). We will use a 30-40-watt power, 1-2 joules and 20-30 MHz frequency for Group A and bipolar en bloc resection for Group B. A 550 nm flexible laser fiber will be used in group A and a bipolar resection loop for group B.

Holmium en bloc resectionbipolar en bloc resection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients of both sexes presented with urinary bladder tumor aiming for complete resection as diagnosed by Ultrasound with or without CT prior histopathological assessment.

You may not qualify if:

  • Patients with signs of extravesical tumor extension where complete resection will not beneficial or unable to proceed to complete resection due to huge tumor burden either huge single tumor more than 5 cm or multiple tumors that are not candidate for complete resection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University Hospitals

Cairo, 11361, Egypt

Location

MeSH Terms

Conditions

Urinary Bladder Neoplasms

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients will be blinded to the type of intervention as well as the data collector and the statistician.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: After obtaining informed consent, patients will be randomized with a 1:1 ratio using sealed envelopes that will be prepared by the department's ethical committee into 2 groups, group 1 represent the Holmium en bloc resection procedure while group 2 represents bipolar en bloc resection. Patients will be blinded to the type of intervention as well as the data collector and the statistician.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

September 16, 2020

First Posted

October 6, 2020

Study Start

July 24, 2020

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

January 28, 2025

Record last verified: 2025-01

Locations